Literature DB >> 22308190

THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.

Corwin M Zigler1, Thomas R Belin.   

Abstract

Motivated by a potential-outcomes perspective, the idea of principal stratification has been widely recognized for its relevance in settings susceptible to posttreatment selection bias such as randomized clinical trials where treatment received can differ from treatment assigned. In one such setting, we address subtleties involved in inference for causal effects when using a key covariate to predict membership in latent principal strata. We show that when treatment received can differ from treatment assigned in both study arms, incorporating a stratum-predictive covariate can make estimates of the "complier average causal effect" (CACE) derive from observations in the two treatment arms with different covariate distributions. Adopting a Bayesian perspective and using Markov chain Monte Carlo for computation, we develop posterior checks that characterize the extent to which incorporating the pretreatment covariate endangers estimation of the CACE. We apply the method to analyze a clinical trial comparing two treatments for jaw fractures in which the study protocol allowed surgeons to overrule both possible randomized treatment assignments based on their clinical judgment and the data contained a key covariate (injury severity) predictive of treatment received.

Entities:  

Year:  2011        PMID: 22308190      PMCID: PMC3269822          DOI: 10.1214/11-AOAS477

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  18 in total

1.  The compliance score as a regressor in randomized trials.

Authors:  Marshall M Joffe; Thomas R Ten Have; Colleen Brensinger
Journal:  Biostatistics       Date:  2003-07       Impact factor: 5.899

2.  Clustered encouragement designs with individual noncompliance: bayesian inference with randomization, and application to advance directive forms.

Authors:  Constantine E Frangakis; Donald B Rubin; Xiao-Hua Zhou
Journal:  Biostatistics       Date:  2002-06       Impact factor: 5.899

3.  Assessing the effect of an influenza vaccine in an encouragement design.

Authors:  K Hirano; G W Imbens; D B Rubin; X H Zhou
Journal:  Biostatistics       Date:  2000-03       Impact factor: 5.899

4.  THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

5.  Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.

Authors:  Bryan E Shepherd; Peter B Gilbert; Yannis Jemiai; Andrea Rotnitzky
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

6.  AN APPLICATION OF PRINCIPAL STRATIFICATION TO CONTROL FOR INSTITUTIONALIZATION AT FOLLOW-UP IN STUDIES OF SUBSTANCE ABUSE TREATMENT PROGRAMS.

Authors:  Beth Ann Griffin; Daniel F McCaffery; Andrew R Morral
Journal:  Ann Appl Stat       Date:  2008-09-01       Impact factor: 2.083

7.  On the analysis of viral load endpoints in HIV vaccine trials.

Authors:  Michael G Hudgens; Antje Hoering; Steven G Self
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

8.  On the use of propensity scores in principal causal effect estimation.

Authors:  Booil Jo; Elizabeth A Stuart
Journal:  Stat Med       Date:  2009-10-15       Impact factor: 2.373

9.  The mandible injury severity score: development and validity.

Authors:  Vivek Shetty; Kathryn Atchison; Claudia Der-Matirosian; Jianming Wang; Thomas R Belin
Journal:  J Oral Maxillofac Surg       Date:  2007-04       Impact factor: 1.895

10.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Authors:  M McClellan; B J McNeil; J P Newhouse
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

View more
  5 in total

1.  THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

2.  Inference on treatment effect modification by biomarker response in a three-phase sampling design.

Authors:  Michal Juraska; Ying Huang; Peter B Gilbert
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

3.  Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.

Authors:  Weining Shen; Jing Ning; Ying Yuan
Journal:  Stat Med       Date:  2015-03-10       Impact factor: 2.373

4.  Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12.

Authors:  Orr-El Weizman; Eric Song; Nicholas M Adams; Andrew D Hildreth; Luke Riggan; Chirag Krishna; Oscar A Aguilar; Christina S Leslie; James R Carlyle; Joseph C Sun; Timothy E O'Sullivan
Journal:  Nat Immunol       Date:  2019-07-01       Impact factor: 25.606

5.  Chromatin states define tumour-specific T cell dysfunction and reprogramming.

Authors:  Mary Philip; Lauren Fairchild; Liping Sun; Ellen L Horste; Steven Camara; Mojdeh Shakiba; Andrew C Scott; Agnes Viale; Peter Lauer; Taha Merghoub; Matthew D Hellmann; Jedd D Wolchok; Christina S Leslie; Andrea Schietinger
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.